Proliferative vitreoretinopathy in the swine- A new model

Investigative Ophthalmology and Visual Science

Volumn 53, Issue 8, 2012, Pages 4910-4916

  Umazume, Kazuhiko ^a   Barak, Yoreh ^a   McDonald, Kevin ^a   Liu, Lanhsin ^a   Kaplan, Henry J ^a   Tamiya, Shigeo ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN; GLIAL FIBRILLARY ACIDIC PROTEIN; GREEN FLUORESCENT PROTEIN; VIMENTIN; ACTIN; FIBRONECTIN; KERATIN; LUMINESCENT AGENT;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EPIRETINAL MEMBRANE; EPITHELIUM CELL; EYE FUNDUS; FEMALE; FLUORESCENCE MICROSCOPY; HISTOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; NONHUMAN; OPHTHALMOSCOPY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RETINA DETACHMENT; RETINAL PIGMENT EPITHELIAL CELL; SWINE; VITRECTOMY; VITREORETINOPATHY; ANIMAL; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; FIBROSIS; METABOLISM; MYOFIBROBLAST; PATHOLOGY; PIGMENT EPITHELIUM; RETINA;

ACTINS; ANIMALS; DISEASE MODELS, ANIMAL; EPIRETINAL MEMBRANE; FEMALE; FIBRONECTINS; FIBROSIS; GREEN FLUORESCENT PROTEINS; KERATINS; LUMINESCENT AGENTS; MYOFIBROBLASTS; RETINA; RETINAL DETACHMENT; RETINAL PIGMENT EPITHELIUM; SWINE; VITREORETINOPATHY, PROLIFERATIVE;

EID: 84867325716     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.12-9768     Document Type: Article

References (39)

1. The classification of retinal detachment with proliferative vitreoretinopathy. Ophthalmology. 1983;90:121-125.
2. Heimann H, Bornfeld N, Friedrichs W, et al. Primary vitrectomy without scleral buckling for rhegmatogenous retinal detachment. Graefes Arch Clin Exp Ophthalmol. 1996;234:561-568.
3. Hakin KN, Lavin MJ, Leaver PK. Primary vitrectomy for rhegmatogenous retinal detachment. Graefes Arch Clin Exp Ophthalmol. 1993;231:344-346.
4. Saw SM, Gazzard G, Wagle AM, Lim J, Au Eong KG. An evidence-based analysis of surgical interventions for uncomplicated rhegmatogenous retinal detachment. Acta Ophthalmol Scand. 2006;84:606-612.
5. Heussen N, Feltgen N, Walter P, Hoerauf H, Hilgers RD, Heimann H. Scleral buckling versus primary vitrectomy in rhegmatogenous retinal detachment study (SPR study): predictive factors for functional outcome. Study report no. 6. Graefes Arch Clin Exp Ophthalmol. 2011;249:1129-1136.
6. Vitrectomy with silicone oil or perfluoropropane gas in eyes with severe proliferative vitreoretinopathy: results of a randomized clinical trial. Silicone study report 2. Arch Ophthalmol. 1992;110:780-792.
7. Foster RE, Meyers SM. Recurrent retinal detachment morethan 1 year after reattachment. Ophthalmology. 2002;109: 1821-1827.
8. Machemer R. Pathogenesis and classification of massive periretinal proliferation. Br J Ophthalmol. 1978;62:737-747.
9. Hiscott P, Sheridan C, Magee RM, Grierson I. Matrix and the retinal pigment epithelium in proliferative retinal disease. Prog Retin Eye Res. 1999;18:167-190.
10. Nagasaki H, Shinagawa K, Mochizuki M. Risk factors for proliferative vitreoretinopathy. Prog Retin Eye Res. 1998;17: 77-98.
11. Pastor JC, de la Rua ER, Martin F. Proliferative vitreoretinopathy: risk factors and pathobiology. Prog Retin Eye Res. 2002; 21:127-144.
12. Grisanti S, Guidry C. Transdifferentiation of retinal pigment epithelial cells from epithelial to mesenchymal phenotype. Invest Ophthalmol Vis Sci. 1995;36:391-405.
13. Tamiya S, Liu L, Kaplan HJ. Epithelial-mesenchymal transition and proliferation of retinal pigment epithelial cells initiated upon loss of cell-cell contact. Invest Ophthalmol Vis Sci. 2010; 51:2755-2763.
14. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest. 2009;119:1420-1428.
15. Agrawal RN, He S, Spee C, Cui JZ, Ryan SJ, Hinton DR. In vivo models of proliferative vitreoretinopathy. Nature Protoc. 2007;2:67-77.
16. Canto Soler MV, Gallo JE, Dodds RA, Suburo AM. A mouse model of proliferative vitreoretinopathy induced by dispase. Exp Eye Res. 2002;75:491-504.
17. Fastenberg DM, Diddie KR, Sorgente N, Ryan SJ. A comparison of different cellular inocula in an experimental model of massive periretinal proliferation. Am J Ophthalmol. 1982;93: 559-564.
18. Frenzel EM, Neely KA, Walsh AW, Cameron JD, Gregerson DS. A new model of proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci. 1998;39:2157-2164.
19. Radtke ND, Tano Y, Chandler D, Machemer R. Simulation of massive periretinal proliferation by autotransplantation of retinal pigment epithelial cells in rabbits. Am J Ophthalmol. 1981;91:76-87.
20. Sanchez I, Martin R, Ussa F, Fernandez-Bueno I. The parameters of the porcine eyeball. Graefes Arch Clin Exp Ophthalmol. 2011;249:475-482.
21. Johansson UE, Eftekhari S, Warfvinge K. A battery of celland structure-specific markers for the adult porcine retina. J Histochem Cytochem. 2010;58:377-389.
22. Li ZY, Wong F, Chang JH, et al. Rhodopsin transgenic pigs as a model for human retinitis pigmentosa. Invest Ophthalmol Vis Sci. 1998;39:808-819.
23. Sonoda S, Spee C, Barron E, Ryan SJ, Kannan R, Hinton DR. A protocol for the culture and differentiation of highly polarized human retinal pigment epithelial cells. Nat Protoc. 2009;4: 662-673.
24. Machemer R, Aaberg TM, Freeman HM, Irvine AR, Lean JS, Michels RM. An updated classification of retinal detachment with proliferative vitreoretinopathy. Am J Ophthalmol. 1991; 112:159-165.
25. Fastenberg DM, Diddie KR, Dorey K, Ryan SJ. The role of cellular proliferation in an experimental model of massive periretinal proliferation. Am J Ophthalmol. 1982;93:565-572.
26. Hui YN, Goodnight R, Sorgente N, Ryan SJ. Fibrovascular proliferation and retinal detachment after intravitreal injection of activated macrophages in the rabbit eye. Am J Ophthalmol. 1989;108:176-184.
27. Peters MA, Burke JM, Clowry M, Abrams GW, Williams GA. Development of traction retinal detachments following intravitreal injections of retinal Muller and pigment epithelial cells. Graefes Arch Clin Exp Ophthalmol. 1986;224:554-563.
28. Bertschinger DR, Beknazar E, Simonutti M, et al. A review of in vivo animal studies in retinal prosthesis research. Graefes Arch Clin Exp Ophthalmol. 2008;246:1505-1517.
29. Garcia-Layana A, Pastor JC, Saornil MA, Gonzalez G. Porcine model of proliferative vitreoretinopathy with platelets. Curr Eye Res. 1997;16:556-563.
30. Machemer R, Laqua H. Pigment epithelium proliferation in retinal detachment (massive periretinal proliferation). Am J Ophthalmol. 1975;80:1-23.
31. Schmitt-Graff A, Desmouliere A, Gabbiani G. Heterogeneity of myofibroblast phenotypic features: an example of fibroblastic cell plasticity. Virchows Arch. 1994;425:3-24.
32. Desmouliere A, Chaponnier C, Gabbiani G. Tissue repair, contraction, and the myofibroblast. Wound Repair Regen. 2005;13:7-12.
33. Saika S, Kono-Saika S, Tanaka T, et al. Smad3 is required for dedifferentiation of retinal pigment epithelium following retinal detachment in mice. Lab Invest. 2004;84:1245-1258.
34. Casaroli Marano RP, Vilaro S. The role of fibronectin, laminin, vitronectin and their receptors on cellular adhesion in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci. 1994;35:2791-2803.
35. Imai Y, Ibata I, Ito D, Ohsawa K, Kohsaka S. A novel gene iba1 in the major histocompatibility complex class III region encoding an EF hand protein expressed in a monocytic lineage. Biochem Biophys Res Commun. 1996;224:855-862.
36. Ito D, Imai Y, Ohsawa K, Nakajima K, Fukuuchi Y, Kohsaka S. Microglia-specific localisation of a novel calcium binding protein, Iba1. Brain Res Mol Brain Res. 1998;57:1-9.
37. Yamashita H, Hori S, Masuda K. Population and proportion of component cells in preretinal membranes. Jpn J Ophthalmol. 1986;30:269-281.
38. Morino I, Hiscott P, McKechnie N, Grierson I. Variation in epiretinal membrane components with clinical duration of the proliferative tissue. Brit J Ophthalmol. 1990;74:393-399.
39. Sramek SJ, Wallow IH, Stevens TS, Nork TM. Immunostaining of preretinal membranes for actin, fibronectin, and glial fibrillary acidic protein. Ophthalmology. 1989;96:835-841.